Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same

MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same

US Patent 11618770 · Granted Apr 4, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
Anti-GPC3 antibody2024
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of t2024
Immunocompetent cell and expression vector expressing regulatory factors of immu2024
Medicine for treating cancer by administering a toll-like receptor agonist and L2023
Medicine for treating cancer by administering a toll-like receptor agonist and L2023
Anti-GPC3 antibody2023
Method for assisting prediction of risk of occurrence of side effect of irinotec2023